Latest news with #SleepApnea
Yahoo
2 days ago
- Health
- Yahoo
Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR
DELRAY BEACH, Fla., July 18, 2025 /PRNewswire/ -- The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2032, culminating in a forecasted valuation of US$11.6 billion by the end of the period. The sleep apnea devices market is experiencing significant growth, primarily driven by the increasing integration of telemedicine, mobile health (mHealth), and artificial intelligence in the diagnostic and therapeutic processes for sleep apnea. The expansion of key market players into emerging economies like India, Australia, the UAE, and Saudi Arabia is further enhancing this market's potential. Additionally, there is a notable trend among health agencies to expand reimbursement policies for remote patient monitoring and related connected healthcare services, which is improving accessibility to advanced sleep apnea management solutions. Furthermore, innovative developments such as compact positive airway pressure (PAP) devices and wearable sleep monitoring technologies are gaining traction, reshaping the dynamics of the sleep apnea devices market. Download PDF Brochure: Browse in-depth TOC on 'Sleep Apnea Devices Market' 739 - Tables51 - Figures497 - Pages By product type, the sleep apnea devices market is categorized into two main product types: therapeutic devices and diagnostic devices. In 2024, the therapeutic devices segment emerged as the dominant player in the market, capturing the largest share. This growth can be attributed to continuous advancements in technology focused on increasing patient comfort and enhancing the overall user experience, which in turn fosters better adherence to therapy. Leading the charge in this segment are prominent companies such as ResMed from the United States, Koninklijke Philips N.V. based in the Netherlands, and Fisher & Paykel Healthcare Limited from New Zealand, all of which are renowned for their innovative solutions in the field of sleep apnea management. By end users, the sleep apnea devices market is segmented by end user into several categories, including hospitals, home care settings, sleep clinics, ambulatory care centers, primary care centers, and other specialized end users. As we look ahead to 2024, it is anticipated that home care settings and individual users will dominate the market, capturing the largest share. This trend can be attributed to a growing preference for home-based diagnosis and treatment options, which effectively eliminates the need for patients to travel to sleep centers for their care. The convenience of being able to monitor and manage sleep apnea from the comfort of one's home has significantly enhanced the accessibility of these devices. This shift not only appeals to patients seeking a more comfortable treatment experience but also addresses the ongoing demand for efficient and timely care in the face of increasing patient volumes. Ultimately, these factors collaborate to drive substantial growth in the market for sleep apnea devices. By geography, the global market for sleep apnea devices has been segmented into six major geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these regions, North America stood out as the largest market for sleep apnea devices in 2024. Several factors contribute to North America's market leadership. Firstly, there is a high level of public awareness regarding sleep apnea and its associated health risks, which encourages individuals to seek diagnosis and treatment. Additionally, the region boasts widespread access to advanced diagnostic technologies, enabling healthcare providers to accurately identify sleep apnea cases and recommend appropriate devices. Moreover, favorable reimbursement policies play a significant role in facilitating the adoption of these medical devices. Insurers are increasingly covering expenses related to sleep apnea treatments, making it more financially viable for patients to invest in devices that improve their quality of sleep and overall health. As a result, the combination of heightened awareness, access to cutting-edge technology, and supportive healthcare policies has led to a notable increase in the adoption of sleep apnea devices throughout North America. Request Sample Pages: The major players operating in this market are ResMed (US), Koninklijke Philips N.V. (Netherlands), Fisher & Paykel Healthcare Limited (New Zealand), Inspire Medical Systems, Inc. (US), SomnoMed (Australia), Openairway (Canada), Compumedics Limited (Australia), Löwenstein Medical SE & Co. KG (Germany), Drive DeVilbiss International (US), BMC (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Holdings Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. KG (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US) ResMed (US): In 2024, ResMed, a leading company based in the United States, captured the largest market share in the global sleep apnea devices sector. The company has built a strong reputation for its innovative and highly effective therapeutic and diagnostic solutions, particularly in sleep health. ResMed's success is primarily attributed to its extensive expertise in healthcare technology, which allows it to develop sleep apnea devices that deliver both accuracy and efficacy in treatment. Over the past few years, ResMed has significantly broadened its product portfolio, focusing on positive airway pressure (PAP) devices and facial interfaces that enhance user comfort and compliance. This expansion diversifies its offerings and positions ResMed to meet broader patient needs and preferences. By continually advancing its technology and product design, the company has maintained its status as the market leader in sleep apnea solutions. It is committed to improving patient outcomes and quality of life. Koninklijke Philips N.V. (Netherlands) Koninklijke Philips N.V., headquartered in the Netherlands, was the second-largest company in market share in 2024. Renowned for its expertise in the sleep apnea sector, Philips has established itself as a vital contributor to health monitoring and respiratory care. The company has gained recognition for its innovative and user-centric devices designed to enhance the quality of life for individuals suffering from sleep apnea. In recent years, Philips has sought to expand its global presence through strategic partnerships and acquisitions. These initiatives aim to improve accessibility to sleep apnea solutions and increase awareness about the condition, particularly in emerging and developing markets where health challenges are often underrecognized. By aligning with local healthcare providers and leveraging regional insights, Philips is working to ensure that effective treatment options reach a wider audience, contributing to better overall health outcomes for sleep apnea patients. Fisher & Paykel Healthcare Limited (New Zealand) Fisher & Paykel Healthcare Limited, based in New Zealand, is anticipated to capture the third-largest market share of sleep apnea devices by 2024. The company strategically distributes its innovative sleep apnea products across two primary segments: the Hospital and Homecare sectors. Fisher & Paykel is committed to elevating patient care by continuously enhancing its product offerings, emphasizing advanced humidification systems and state-of-the-art mask technologies. These improvements are designed to improve patient comfort during therapy and optimize therapeutic outcomes, ensuring that users experience effective and comfortable treatment for their sleep apnea. Through these efforts, the company aims to solidify its position as a leader in the sleep apnea market while improving the quality of life for patients globally. For more information, Inquire Now! Related Reports: Pulse Oximeter Market Patient Monitoring Devices Market Home Healthcare Market Respiratory Care Devices Market Top 10 Medical Device Technologies Market Get access to the latest updates on Sleep Apnea Devices Companies and Sleep Apnea Devices Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNN
6 days ago
- CNN
Dismantling the Education Department, training air traffic controllers, nicotine patch warning: Catch up on the day's stories
5 Things Aviation news Air travel safety Drugs in society FacebookTweetLink 👋 Welcome to 5 Things PM! It's a potentially serious medical condition, yet lots of people don't know they have obstructive sleep apnea. Most treatments — like CPAP devices — blow air into the mouth. But an alternative technology sucks air instead. Is it onto something? Here's what else you might have missed during your busy day. In the latest victory for President Donald Trump, the Supreme Court's conservative majority said he can proceed with plans to carry out mass layoffs at the Department of Education. In a scathing dissent, Justice Sonia Sotomayor warned of 'untold harm.' The conspiracy-soaked culture that propelled Trump to political power is now coming for him. Some of the most influential voices in right-wing media are rejecting Trump's call to stop wasting 'time and energy on Jeffrey Epstein.' Nicotine pouches are surging in popularity, but a new study found that they're a fast-growing source of poisoning in young children. Some people think the little white packets that you tuck between your lip and gum taste good thanks to flavorings and sweeteners. On a sprawling campus in Oklahoma City, thousands of students learn how to take command of the nation's skies. The FAA Academy teaches air traffic controllers to keep passengers safe while planes take off, land and cruise at 30,000 feet. Lucy Jones painted her first nude self-portrait when she was 50. The British artist's latest show captures her life with cerebral palsy through the years, and it's a brash and witty exploration of physical disability. GET '5 THINGS' IN YOUR INBOX If your day doesn't start until you're up to speed on the latest headlines, then let us introduce you to your new favorite morning fix. Sign up here for the '5 Things' newsletter. 🛸 What is that? Journalist and UFO enthusiast Jeremy Corbell released footage, reportedly captured by the US military in 2020, of a disc-shaped unidentified flying object. The Pentagon declined to answer CNN's questions on the validity of the video. Trump announces novel plan to send weapons to Ukraine and gives Russia new deadline to make peace 9 dead in Massachusetts assisted living facility fire described as 'unfathomable tragedy' Obama's blunt message for Democrats: 'Toughen up' 📺 That's how many times French gameshow star Émilien won before losing his record-breaking 21-month streak from one flub. 🌋 Ash-tounding! In future regions, could everything you touch actually be lava? An Icelandic firm proposed a project that redirects and harnesses the volcanic material with various cooling methods to create whole cities. 'I think I was a little bit in shock after as well, but I told myself I'll definitely come out stronger after this.' Amanda Anisimova 🎾 Bouncing back: The American tennis player vowed to return stronger after being 'frozen' with nerves during her 6-0, 6-0 loss to Iga Świątek in the Wimbledon women's final. 🌌 What type of galaxy was recently discovered 3 billion light-years away?A. Spiral galaxyB. Cubed galaxyC. Fossil galaxyD. Elliptical galaxy⬇️ Scroll down for the answer. 🎒 Packing light: Glen Van Peski is a legend in the world of backpacking. He spent decades shaving unnecessary weight until he narrowed his gear down to just a few pounds. See what he chose to keep and how it changed his perspective on life. 👋 We'll see you tomorrow.🧠 Quiz answer: C. Astronomers discovered a fossil galaxy that has remained unchanged for 7 billion years — a virtually inactive time capsule.📧 Check out all of CNN's newsletters. Today's edition of 5 Things PM was edited and produced by CNN's Kimberly Richardson, Sarah Hutter and Emily Scolnick.
India Today
19-06-2025
- Health
- India Today
Nighttime symptoms that are big red flags for your heart, liver and kidneys
Do you wake up often at night to urinate, struggle to breathe while lying down, or wake up sweating for no clear reason? These could be signs of more than just poor sleep -- they might point to serious problems with your heart, kidneys, or say nighttime symptoms are often ignored, but they can be early red flags for heart failure, blocked arteries, chronic kidney disease (CKD), and even liver frequent night urination could mean heart or kidney trouble Getting up often at night to urinate, called nocturia, is more than just annoying. It can be an early sign of heart failure or kidney disease."During the day, in heart failure, the body holds on to fluid, especially in the legs. At night, when you lie down, this fluid moves back into the bloodstream and is filtered by the kidneys, making you urinate more. In kidney disease, the kidneys lose their ability to concentrate urine, so you make more urine both day and night, but nighttime urination is usually more noticeable and disturbing," Dr. Vikram B Kolhari, senior cardiologist at Apollo nighttime urination is chronic and comes with swelling in the legs, fatigue, or shortness of breath, it's time to see a trouble and sweating at night? Don't ignore itBreathlessness while lying down or suddenly waking due to shortness of breath can be warning signs. Getting up often at night to urinate, called nocturia, is an early sign of heart failure or kidney disease. () 'Shortness of breath at night can mean your heart isn't pumping blood well, causing fluid to build up in the lungs,' says Dr. signs include: night sweats caused by your heart working extra hard due to blocked arteries, chest discomfort or pain due to pressure, tightness, or squeezing, especially if it wakes you up or comes with breathlessness, and sleep apnea involving disrupted breathing during sleep can be linked to heart problems and high blood of restful sleep can itself increase blood pressure and strain the heart over or restless legs linked to liver issuesMany people with liver problems notice their sleep quality gets worse.'Most people with liver disease find their sleep is affected. You might get insomnia or feel un-refreshed after sleep,' says Dr. Shalini Bhutta, consultant physician at Neotia Mediplus OPD & Diagnostics may take longer to fall asleep, or wake up often. Some even report restless legs, an urge to move the legs, especially at nigh, which may be linked to liver function. Shortness of breath at night can mean your heart isn't pumping blood well. () Not every sleep issue means disease, but some symptoms shouldn't be ignored.'Frequent sleep disturbances, poor sleep quality, breathing problems, chest pain, or persistent anxiety at night are signs to consult a doctor,' says Dr. sleep–heart connection: Why sleep apnea is dangerousObstructive Sleep Apnea (OSA) is more than loud snoring or tiredness. It can put serious pressure on your heart. It is linked to high blood pressure, heart rhythm issues, and even heart attacks, says Dr. with OSA often stop breathing multiple times during the night, which lowers oxygen and increases stress on the heart. People with OSA often stop breathing multiple times during the night, which lowers oxygen and increases stress on the heart. () advertisementOver time, this can lead to heart failure, stroke, and metabolic problems like diabetes and to see a doctorIf you notice any of these nighttime symptoms:Waking up often to urinateFeeling breathless while lying downWaking up with chest pain or sweatingInsomnia or restless legsConstant poor sleep or fatigueThese could be your body's way of warning you about your heart, liver, or kidneys.
Phone Arena
06-06-2025
- Health
- Phone Arena
Samsung finally brings this key Galaxy Watch health feature to more countries
Samsung Galaxy Watch Ultra supports the Sleep Apnea feature | Image credit: PhoneArena Modern smartwatches come with throngs of health and fitness features, which have become a necessity for customers these days. The ability to monitor blood pressure, heart rate and sleep just by wearing a smartwatch was something unthinkable several years smartwatches are among the most advanced on the market, but there's one issue that prevents them from being even better. Some of the health features that come with the Galaxy Watch series are not available in all countries because they haven't yet been approved by the required authorities. The Sleep Apnea feature on the Galaxy Watch series, which is available via the Samsung Health Monitor app, was initially released in 34 countries. That's pretty low considering that the Galaxy Watch series is selling in just about every corner of the world. The good news is Samsung is slowly rolling out the key health feature to more countries. Earlier today, the South Korean giant announced that Sleep Apnea has finally been approved by the European Conformity organization, allowing Samsung to expand the feature to 34 European Australia's Therapeutic Goods Administration and Singapore's Health Sciences Authority approved the feature too, Sleep Apnea is coming to these countries as well. The Sleep Apnea feature is available on Galaxy Watch 4 series and later models running Wear OS 5.0 or later and must be paired with a Galaxy smartphone running Android 12.0 or later. The Sleep Apnea feature requires a Galaxy Watch 4 series or later model | Image credit: Samsung With the addition of the new markets, the Sleep Apnea feature is now available in 70 markets, including Australia, Austria, Azerbaijan, Bahrain, Belgium, Bolivia, Brazil, Bulgaria, Canada, Chile, Christmas Island, Cocos (Keeling) Islands, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Estonia, Faroe Islands, Finland, France, Georgia, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, Ireland, Italy, Kuwait, Latvia, Lithuania, Luxembourg, Malta, Mauritius, Mayotte, Mexico, Netherlands, Nicaragua, Norfolk Island, Norway, Oman, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Réunion, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Vietnam and Sleep Apnea feature is meant to detect signs of moderate to severe obstructive sleep apnea, which usually manifests in the form of significant breathing disruptions in adult users age 22 and older over a two-night monitoring period. Naturally, Samsung designed this feature for on-demand use, so it's not intended for those who have already been diagnosed with sleep apnea. Even so, Samsung warns Galaxy Watch users not to rely on this feature as a substitute for professional diagnosis or treatment by a qualified healthcare provider.
